Dr. Monica Shaw is a global executive leader with extensive experience spanning R&D, commercial, and operational functions within the pharmaceutical biotechnology sectors. With a proven track record in executive leadership, Dr. Shaw has excelled in roles encompassing CEO and senior vice president positions across geographies, managing large P&Ls and leading teams of thousands.

As an expert in bringing over 20 products through Phase III to commercialization, she has a strong focus on corporate strategy, organizational design, and go-to-market models, coupled with expertise in product due diligence and business development, financing, and equity fundraising. She has deep therapeutic expertise across Oncology, Immunology, Virology, Neurology, and Rare Diseases, both in clinical settings and within the industry.

Her leadership experience includes:

• SVP Oncology Commercialization: Leading the Commercialization strategy across BMS’s Oncology organization, including the advancement of the therapeutic and disease area strategies, business development, launch planning, as well as leading the U.S. Sales, Marketing and field medical teams.
• SVP Commercial Head CART, BMS: Leading the commercial strategy for BMS’s CART pipeline globally, overseeing the P&L and commercial operations.
• SVP European Markets, BMS: P&L owner for European Markets with over $7 billion in revenue and 2,000 FTEs.
• CEO of Oncopeptides: Led a fully integrated biotech company through the commercial launch of Pepaxti in Multiple Myeloma.
• EVP Head Europe/Canada and Global Marketing for Psoriasis at LEO Pharma: Oversaw a €600m portfolio and led strategic marketing for psoriasis globally.
• VP Head Asia Pacific at GSK/ViiV Healthcare: Spearheaded commercial operations across the region.